The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia
Open accessAbstract
Preeclampsia is a devastating complication of pregnancy. Soluble Fms-like tyrosine kinase-1 (sFlt-1) is an antiangiogenic protein believed to mediate the signs and symptoms of preeclampsia. We conducted an open pilot study to evaluate the safety and potential efficacy of therapeutic apheresis with a plasma-specific dextran sulfate column to remove circulating sFlt-1 in 11 pregnant women (20-38 years of age) with very preterm preeclampsia (23-32 weeks of gestation, systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg, new onset protein/creatinine ratio >0.30 g/g, and sFlt-1/placental growth factor ratio >85). We evaluated the extent of sFlt-1 removal, proteinuria reduction, pregnancy continuation, and neonatal and fetal safety of apheresis after one (n=6), two (n=4), or three (n=1) apheresis treatments. Mean sFlt-1 levels were reduced by 18% (range 7%-28%) with concomitant reductions of 44% in protein/creatinine ratios. Pregnancy continued for 8 days (range 2-11) and 15 days (range 11-21) in women treated once and multiple times, respectively, compared with 3 days (range 0-14) in untreated contemporaneous preeclampsia controls (n=22). Transient maternal BP reduction during apheresis was managed by withholding pre-apheresis antihypertensive therapy, saline prehydration, and reducing blood flow through the apheresis column. Compared with infants born prematurely to untreated women with and without preeclampsia (n=22 per group), no adverse effects of apheresis were observed. In conclusion, therapeutic apheresis reduced circulating sFlt-1 and proteinuria in women with very preterm preeclampsia and appeared to prolong pregnancy without major adverse maternal or fetal consequences. A controlled trial is warranted to confirm these findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maynard, S. E., Min, J.-Y., Merchan, J., Lim, K.-H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17189 · Cited by 4,101
Self-citationCirculating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Self-citationCirculating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Kassebaum, N. J., Bertozzi-Villa, A., Coggeshall, M. S., Shackelford, K. A., Steiner, C., Heuton, K. R., Gonzalez-Medina, D., Barber, R., Huynh, C., Dicker, D., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60696-6 · Cited by 1,644
Cardiovascular sequelae of preeclampsia/eclampsia: A systematic review and meta-analyses
McDonald, S. D., Malinowski, A., Zhou, Q., Yusuf, S., & Devereaux, P. J. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.06.042 · Cited by 924
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
Abalos, E., Duley, L., & Steyn, D. W. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002252.pub3 · Cited by 705
Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia
Rana, S., Powe, C. E., Salahuddin, S., Verlohren, S., Perschel, F. H., Levine, R. J., Lim, K.-H., Wenger, J. B., Thadhani, R., & Karumanchi, S. A. (2012) · Circulation · doi:10.1161/circulationaha.111.054361 · Cited by 668
Sugimoto, H., Hamano, Y., Charytan, D., Cosgrove, D., Kieran, M., Sudhakar, A., & Kalluri, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300012200 · Cited by 538
Walker, J. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02800-2 · Cited by 522
Sibai, B. M., Mercer, B. M., Schiff, E., & Friedman, S. A. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(94)90104-x · Cited by 458
Thadhani, R., Mutter, W. P., Wolf, M., Levine, R. J., Taylor, R. N., Sukhatme, V. P., Ecker, J., & Karumanchi, S. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031244 · Cited by 453
Self-citationAn automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia
Verlohren, S., Galindo, A., Schlembach, D., Zeisler, H., Herraiz, I., Moertl, M. G., Pape, J., Dudenhausen, J. W., Denk, B., & Stepan, H. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.09.016 · Cited by 428
Self-citationPilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia
Thadhani, R., Kisner, T., Hagmann, H., Bossung, V., Noack, S., Schaarschmidt, W., Jank, A., Kribs, A., Cornely, O. A., Kreyssig, C., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.034793 · Cited by 346
Self-citationLi, Z., Zhang, Y., Ying Ma, J., Kapoun, A. M., Shao, Q., Kerr, I., Lam, A., O’Young, G., Sannajust, F., Stathis, P., et al. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.092098 · Cited by 260
Self-citationMaternal Preeclampsia Predicts the Development of Bronchopulmonary Dysplasia
Hansen, A. R., Barnés, C. M., Folkman, J., & McElrath, T. F. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.10.018 · Cited by 229
Gillon, T. E. R., Pels, A., von Dadelszen, P., MacDonell, K., & Magee, L. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113715 · Cited by 210
Rajakumar, A., Michael, H. M., Rajakumar, P. A., Shibata, E., Hubel, C. A., Karumanchi, S. A., Thadhani, R., Wolf, M., Harger, G., & Markovic, N. (2005) · Placenta · doi:10.1016/j.placenta.2004.09.001 · Cited by 190
Self-citationEndometrial VEGF induces placental sFLT1 and leads to pregnancy complications
Fan, X., Rai, A., Kambham, N., Sung, J. F., Singh, N., Petitt, M., Dhal, S., Agrawal, R., Sutton, R. E., Druzin, M. L., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76864 · Cited by 189
Reduction of circulating soluble Flt‐1 alleviates preeclampsia‐like symptoms in a mouse model
Bergmann, A., Ahmad, S., Cudmore, M., Gruber, A. D., Wittschen, P., Lindenmaier, W., Christofori, G., Gross, V., Gonzalves, A. C. D. C., Gröne, H., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00820.x · Cited by 189
Hematologic Complications of Pregnancy
Townsley, D. M. (2013) · Seminars in Hematology · doi:10.1053/j.seminhematol.2013.06.004 · Cited by 177
Prevention of preeclampsia: A big disappointment
Sibai, B. M. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70146-2 · Cited by 172
Gilbert, J. S., Verzwyvelt, J., Colson, D., Arany, M., Karumanchi, S. A., & Granger, J. P. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.141937 · Cited by 168
Self-citationResolution of Hypertension and Proteinuria After Preeclampsia
Berks, D., Steegers, E. A. P., Molas, M., & Visser, W. (2009) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181c14e3e · Cited by 166
Tang, J., Karumanchi, S. A., Seedorf, G., Markham, N. E., & Abman, S. H. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00294.2011 · Cited by 163
Self-citationWhy the kidney glomerulus does not clog: A gel permeation/diffusion hypothesis of renal function
Smithies, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730776100 · Cited by 161
Sunderji, S., Gaziano, E. P., Wothe, D. D., Rogers, L. C., Sibai, B. M., Karumanchi, S. A., & Hodges-Savola, C. A. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.07.025 · Cited by 151
Self-citationAntihypertensive Drugs in Pregnancy
Podymow, T., & August, P. (2011) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2010.10.007 · Cited by 100
Gordon, B. R., Kelsey, S. F., Bilheimer, D. W., Brown, D. C., Dau, P. C., Gotto, A. M., Illingworth, D. R., Jones, P. H., Leitman, S. F., Prihoda, J. S., et al. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90352-y · Cited by 95
Wu, F. T. H., Stefanini, M. O., Gabhann, F. M., & Popel, A. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005108 · Cited by 80
The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome
Schaarschmidt, W., Rana, S., & Stepan, H. (2013) · Journal of Perinatal Medicine · doi:10.1515/jpm-2012-0248 · Cited by 78
Self-citationDifferential Indication of Lipoprotein Apheresis During Pregnancy
Klingel, R., Göhlen, B., Schwarting, A., Himmelsbach, F., & Straube, R. (2003) · Therapeutic Apheresis and Dialysis · doi:10.1046/j.1526-0968.2003.00066.x · Cited by 60
Ohkuchi, A., Hirashima, C., Matsubara, S., Takahashi, K., Matsuda, Y., & Suzuki, M. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.174417 · Cited by 48
Kroon, A. A., Swinkels, D. W., van Dongen, P. W. J., & Stalenhoef, A. F. H. (1994) · Metabolism · doi:10.1016/0026-0495(94)90061-2 · Cited by 45
Wang, A., Holston, A. M., Yu, K., Zhang, J., Toporsian, M., Karumanchi, S. A., & Levine, R. J. (2011) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2011.640368 · Cited by 40
Self-citationTeruel, J. L., Lasunción, M. A., Navarro‐González, J. F., Carrero, P., & Ortuño, J. (1995) · Metabolism · doi:10.1016/0026-0495(95)90247-3 · Cited by 34
Siddiqui, A. H., Irani, R. A., Zhang, Y., Dai, Y., Blackwell, S. C., Ramin, S. M., Kellems, R. E., & Xia, Y. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2010.247 · Cited by 34
From placenta to podocyte: vascular and podocyte pathophysiology in preeclampsia
Wagner, S. J., Craici, I. M., Grande, J. P., & Garovic, V. D. (2012) · Clinical Nephrology · doi:10.5414/cn107321 · Cited by 27
Maternal-Placental-Fetal Unit: Unique Problems of Pharmacologic Study
Ward, R. M. (1989) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)36758-x · Cited by 27
Cited by
Rana (2019) · doi:10.1161/circresaha.118.313276 · Cited by 2,095
Pre-eclampsia: pathophysiology and clinical implications
Burton, G. J., Redman, C. W., Roberts, J. M., & Moffett, A. (2019) · BMJ · doi:10.1136/bmj.l2381 · Cited by 1,250
Pre-eclampsia: pathogenesis, novel diagnostics and therapies
Phipps, E. A., Thadhani, R., Benzing, T., & Karumanchi, S. A. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0119-6 · Cited by 1,191
Self-citationChappell, L. C., Cluver, C. A., Kingdom, J., & Tong, S. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32335-7 · Cited by 925
Connelly‐Smith, L., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., et al. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22043 · Cited by 684
Metadata
- Authors
- Thadhani, R., Hagmann, H., Schaarschmidt, W., Roth, B., Cingoez, T., Karumanchi, S. A., Wenger, J., Lucchesi, K. J., Tamez, H., Lindner, T., Fridman, A., Thome, U., Kribs, A., Danner, M., Hamacher, S., Mallmann, P., Stepan, H., & Benzing, T.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2016-03
- Volume
- 27
- Issue
- 3
- Pages
- 903-913
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2185931826
- Cited by
- 278
- References
- 38
- FWCI
- 32.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.